GGrantIndex
← Leaderboards

Margaret A. Phillips

Ut Southwestern Medical Center

$30,430,817
Attributed
$34,692,148
Total exposure
17
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$34,692,148 · 17

By mechanism

R01$26,080,203 · 6
R37$4,031,152 · 1
R56$1,467,197 · 2
R33$1,392,500 · 1
R21$936,705 · 2
T32$753,641 · 1

Top collaborators

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Parasites

Research focus

ParasitesCellsStructurePharmaceutical PreparationsProgramsDrug DiscoveryEnzymesMetabolismBaseAnabolismBiologyIn VitroHigh Throughput ScreeningInhibitor/AntagonistMetabolicPharmacotherapyPharmaceutical ChemistryIn VivoCombatCessation Of LifeLeadPathway InteractionsPolyaminesSeries

Grant awards (76)

Drug Target Discovery, Validation, and Prioritization for Schistosomiasis$819,288
R01 · FY2025 · AI
Lead Optimization of DHODH Inhibitors for Malaria$748,960
R01 · FY2025 · AI · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$717,556
R01 · FY2025 · AI · contact PI
Drug Target Discovery, Validation, and Prioritization for Schistosomiasis$819,288
R01 · FY2024 · AI
Lead Optimization of DHODH Inhibitors for Malaria$766,060
R01 · FY2024 · AI · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$737,236
R01 · FY2024 · AI · contact PI
POLYAMINE AND TRYPANOTHIONE METABOLISM IN TRYPANOSOMA BRUCEI$445,837
R01 · FY2024 · AI · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$18,655
R01 · FY2024 · AI · contact PI
Drug Target Discovery, Validation, and Prioritization for Schistosomiasis$819,288
R01 · FY2023 · AI
Lead Optimization of DHODH Inhibitors for Malaria$755,889
R01 · FY2023 · AI · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$737,236
R01 · FY2023 · AI · contact PI
POLYAMINE AND TRYPANOTHIONE METABOLISM IN TRYPANOSOMA BRUCEI$445,837
R01 · FY2023 · AI · contact PI
Chemistry-Biology Interface T32$154,881
T32 · FY2023 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$81,180
R01 · FY2023 · AI · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$737,236
R01 · FY2022 · AI · contact PI
Lead Optimization of DHODH Inhibitors for Malaria$723,733
R01 · FY2022 · AI · contact PI
POLYAMINE AND TRYPANOTHIONE METABOLISM IN TRYPANOSOMA BRUCEI$445,837
R01 · FY2022 · AI · contact PI
Chemistry-Biology Interface T32$161,169
T32 · FY2022 · GM · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$62,525
R01 · FY2022 · AI · contact PI
Optimization of novel phenotypic screening hits for treatment of Malaria$752,336
R01 · FY2021 · AI · contact PI
Lead Optimization of DHODH Inhibitors for Malaria$726,917
R01 · FY2021 · AI · contact PI
Targeting trypanosomatid deoxyhypusine synthase$459,000
R33 · FY2021 · AI · contact PI
POLYAMINE AND TRYPANOTHIONE METABOLISM IN TRYPANOSOMA BRUCEI$445,614
R01 · FY2021 · AI · contact PI
Chemistry-Biology Interface T32$148,076
T32 · FY2021 · GM · contact PI
Lead Optimization of DHODH Inhibitors for Malaria$728,403
R01 · FY2020 · AI · contact PI
Targeting trypanosomatid deoxyhypusine synthase$459,000
R33 · FY2020 · AI · contact PI
POLYAMINE AND TRYPANOTHIONE METABOLISM IN TRYPANOSOMA BRUCEI$444,276
R01 · FY2020 · AI · contact PI
Chemistry-Biology Interface T32$145,846
T32 · FY2020 · GM · contact PI
Lead Optimization of DHODH Inhibitors for Malaria$727,804
R01 · FY2019 · AI · contact PI
Targeting trypanosomatid deoxyhypusine synthase$474,500
R33 · FY2019 · AI · contact PI
Chemistry-Biology Interface T32$143,669
T32 · FY2019 · GM · contact PI
DHODH Inhibitors: A Potential New Class of Antimicrobials for Treatment of the Drug Resistant Gram-Negative Bacillus Acinetobacter baumannii$981,697
R56 · FY2018 · AI
Lead Optimization of DHODH Inhibitors for Malaria$757,086
R01 · FY2018 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$397,500
R37 · FY2018 · AI · contact PI
Targeting trypanosomatid deoxyhypusine synthase$202,500
R21 · FY2018 · AI · contact PI
2018 Biology of Host Parasite Interactions Gordon Research Conference and Gordon Research Seminar$5,500
R13 · FY2018 · AI · contact PI
Lead optimization of DHODH inhibitors for malaria$595,447
R01 · FY2017 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$397,500
R37 · FY2017 · AI · contact PI
Targeting trypanosomatid deoxyhypusine synthase$243,000
R21 · FY2017 · AI · contact PI
Lead optimization of DHODH inhibitors for malaria$595,447
R01 · FY2016 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$449,003
R37 · FY2016 · AI · contact PI
Lead optimization of DHODH inhibitors for malaria$595,447
R01 · FY2015 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$490,363
R37 · FY2015 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$39,096
R37 · FY2015 · AI · contact PI
Targeting S-adenosylmethionine decarboxylase for HAT drug discovery$826,050
R01 · FY2014 · AI · contact PI
Lead optimization of DHODH inhibitors for malaria$595,447
R01 · FY2014 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$376,850
R37 · FY2014 · AI · contact PI
Targeting S-adenosylmethionine decarboxylase for HAT drug discovery$802,730
R01 · FY2013 · AI · contact PI
Lead optimization of DHODH inhibitors for malaria$636,297
R01 · FY2013 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$360,282
R37 · FY2013 · AI · contact PI
Targeting S-adenosylmethionine decarboxylase for HAT drug discovery$838,349
R01 · FY2012 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$383,279
R37 · FY2012 · AI · contact PI
Targeting S-adenosylmethionine decarboxylase for HAT drug discovery$833,519
R01 · FY2011 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$383,279
R37 · FY2011 · AI · contact PI
Targeting S-adenosylmethionine decarboxylase for HAT drug discovery$829,317
R01 · FY2010 · AI · contact PI
Targeting Malarial Dihydroorotate Dehydrogenase$485,500
R56 · FY2010 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$378,600
R37 · FY2010 · AI · contact PI
Polyamine and trypanothione metabolism in Trypanosoma brucei$375,400
R37 · FY2009 · AI · contact PI
Targeting malarial dihydroorotate dehydrogenase$405,500
R01 · FY2008 · AI · contact PI
Polyamine and glutathione metabolism in trypanosomes.$326,489
R01 · FY2008 · AI · contact PI
Targeting malarial dihydroorotate dehydrogenase$402,361
R01 · FY2007 · AI · contact PI
Polyamine and glutathione metabolism in trypanosomes.$332,812
R01 · FY2007 · AI · contact PI
2007 Polyamines Gordon Conference and Graduate Research Seminar$6,500
R13 · FY2007 · AI · contact PI
Targeting malarial dihydroorotate dehydrogenase$403,384
R01 · FY2006 · AI · contact PI
Polyamine and glutathione metabolism in trypanosomes.$342,752
R01 · FY2006 · AI · contact PI
Targeting malarial dihydroorotate dehydrogenase$403,618
R01 · FY2005 · AI
Polyamine and glutathione metabolism in trypanosomes.$351,000
R01 · FY2005 · AI
Conference on Drugs Against Protozoan Parasites$13,750
R13 · FY2005 · AI
Polyamine and glutathione metabolism in trypanosomes.$331,400
R01 · FY2004 · AI
Targeting malarial dihydroorotate dehydrogenase$130,998
R01 · FY2004 · AI
Targeting malarial dihydroorotate dehydrogenase$491,205
R21 · FY2003 · AI
TRYPANOSMIASIS--MOLECULAR APPROACHES TO CHEMOTHERAPY$276,943
R01 · FY2003 · AI
TRYPANOSMIASIS--MOLECULAR APPROACHES TO CHEMOTHERAPY$268,994
R01 · FY2002 · AI
Polyamine metabolism as a drug target in protozoa$5,000
R13 · FY2002 · AI
TRYPANOSMIASIS--MOLECULAR APPROACHES TO CHEMOTHERAPY$251,205
R01 · FY2001 · AI
TRYPANOSMIASIS--MOLECULAR APPROACHES TO CHEMOTHERAPY$240,620
R01 · FY2000 · AI